Impact of estrogen type on cardiovascular safety of combined oral contraceptives
- 1 October 2016
- journal article
- research article
- Published by Elsevier BV in Contraception
- Vol. 94 (4), 328-339
- https://doi.org/10.1016/j.contraception.2016.06.010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal RingObstetrics & Gynecology, 2013
- The Value of Family History as a Risk Indicator for Venous ThrombosisJAMA Internal Medicine, 2009
- Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 3: Principles of causality in epidemiological research: statistical stability, dose- and duration-response effects, internal and external consistency, analogy and biological plausibilityBMJ Sexual & Reproductive Health, 2008
- Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy Part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of associationBMJ Sexual & Reproductive Health, 2008
- The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observationContraception, 2007
- Effect of four oral contraceptives on hemostatic parametersContraception, 2004
- Venous Thromboembolism from Air TravelAngiology, 2001
- Epidemiology Faces Its LimitsScience, 1995
- Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogensTeratology, 1992
- A Strengthening Programme for Weak AssociationsInternational Journal of Epidemiology, 1988